Table 1 Demographic and clinical characteristics of nAMD patients and controls.
From: Alterations in Circulating Immune Cells in Neovascular Age-Related Macular Degeneration
All (n= 129) | Controls (n= 26) | nAMD (n= 103) | P value nAMD vs Control | |
---|---|---|---|---|
Age (median (range)), years | 79.1 (53–94) | 76.7 (59–92) | 79.5 (53–94) | 0.0651 |
Female sex (number (%)) | 70 (54) | 12 (46) | 58 (56) | 0.3852 |
Have history of AMD (number (%)) | 30 (23) | 5 (19) | 25 (24) | 0.7962 |
Have history of cardiovascular disease (number (%)) | 29 (22) | 7 (27) | 22 (21) | 0.6012 |
Have history of hypertension (number (%)) | 75 (58) | 17 (65) | 58 (56) | 0.5062 |
Have history of diabetes (number (%)) | 15 (12) | 2 (8) | 13 (13) | 0.7342 |
Body Mass Index (mean ± SD) | 26.4 (4.9) | 27.1 (5.6) | 26.1 (4.7) | 0.3973 |
Smoking status | 0.6332 | |||
Non-smoker (number (%)) | 52 (40) | 11 (42) | 41 (40) | |
Former smoker (number (%)) | 66 (51) | 14 (54) | 52 (50) | |
Current smoker (number (%)) | 11 (9) | 1 (4) | 10 (10) | |
Taking cardiovascular medication (number (%)) | 90 (87) | 19 (73) | 71 (69) | 0.8132 |
Taking vitamins (number (%)) | 25 (19) | 2 (8) | 23 (22) | 0.1042 |
Taking low-dose aspirin (number (%)) | 41(32) | 4 (15) | 37 (36) | 0.0592 |